Goserelin decision offers long-term fix to PBS uncertainty

3 minute read


The PBAC recommendation could secure another treatment option for thousands of women affected by the looming withdrawal of monthly goserelin, while reducing the need for frequent injections.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×